Initiation of coverage of the MedinCell share by TPICAP Midcap with a study entitled “Maturation of the pipeline: 1st launch likely in H1-23”, recommending the purchase value with a target price of 15 euros per share.
To receive all of MedinCell’s financial information in real time, send a request by email to [email protected]. Your registration will be immediate.